New drugs take aim at one of cancer’s deadliest mutations - Nature

New drugs take aim at one of cancer’s deadliest mutations  NatureSetidegrasib in Advanced NSCLC and Pancreatic Cancer Harboring the KRAS p.G12D Variant  The ASCO PostBreakthrough drugs could finally tackle deadliest ‘undruggable’ cancer mutation  The News InternationalErika Hamilton on Advancing KRAS G12D Targeting in Lung and Pancreatic Cancer  OncodailyFlorida Cancer Specialists & Research Institute Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic Cancers  PR Newswire